You Jiayin, Su Ning, Feng Xiaoran, Peng Fenfen, Xu Qingdong, Zhan Xiaojiang, Wen Yueqiang, Wang Xiaoyang, Tian Na, Wu Xianfeng, Wang Niansong
Department of Nephrology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Department of Nephrology, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Ren Fail. 2025 Dec;47(1):2497493. doi: 10.1080/0886022X.2025.2497493. Epub 2025 May 19.
End-stage renal disease (ESRD) is often complicated by left ventricular dysfunction, which is associated with a poor prognosis. This study aims to investigate the association between baseline left ventricular ejection fraction (LVEF) plus left ventricular end-diastolic diameter (LVEDD) with outcomes in peritoneal dialysis (PD) patients. In this multicenter retrospective study, 1,511 incident Chinese patients on PD between 1 January 2005 and 31 December 2021 were enrolled. Restricted cubic splines (RCS) were used to explore the non-linear associations between LVEF+LVEDD and the risk of mortality. Parametric models for interval-censored survival-time data (stintreg) were used to examine the association between LVEF+LVEDD quartiles and the outcomes. During 6,451.11 person-years of follow-up [median 4.81 (IQR 3.61-6.81) years], 247 (17.8%) patients died, including 88 cardiovascular deaths. RCS showed a U-shaped association between LVEF+LVEDD and the risks of all-cause and CV mortality. According to the quartiles, the optimal range of LVEF+LVEDD associated with the lowest risk of all-cause and CV mortality was 103-107, which was set as the reference range. Both higher (≥115) and lower (<103) levels of LVEF+LVEDD were associated with increased risks of all-cause mortality (hazard ratio [HR] 2.20, 95% confidence interval [CI] 1.58-3.07; HR 1.68, 95% CI 1.19-2.36) and cardiovascular mortality (HR 2.51, 95% CI 1.33-4.75; HR 1.86, 95% CI 0.96-3.61). Low and high levels of baseline LVEF+LVEDD were associated with increased risks of all-cause and cardiovascular mortality in PD patients.
终末期肾病(ESRD)常并发左心室功能障碍,这与预后不良相关。本研究旨在探讨基线左心室射血分数(LVEF)加左心室舒张末期内径(LVEDD)与腹膜透析(PD)患者预后之间的关联。在这项多中心回顾性研究中,纳入了2005年1月1日至2021年12月31日期间开始接受PD治疗的1511例中国新发病例。采用限制性立方样条(RCS)来探究LVEF+LVEDD与死亡风险之间的非线性关联。使用区间删失生存时间数据的参数模型(stintreg)来检验LVEF+LVEDD四分位数与预后之间的关联。在6451.11人年的随访期间[中位随访时间4.81(四分位间距3.61 - 6.81)年],247例(17.8%)患者死亡,其中88例为心血管死亡。RCS显示LVEF+LVEDD与全因死亡和心血管死亡风险之间呈U形关联。根据四分位数,与全因死亡和心血管死亡风险最低相关的LVEF+LVEDD最佳范围为103 - 107,将其设定为参考范围。LVEF+LVEDD较高(≥115)和较低(<103)水平均与全因死亡风险增加相关(风险比[HR] 2.20,95%置信区间[CI] 1.58 - 3.07;HR 1.68,95% CI 1.19 - 2.36)以及心血管死亡风险增加相关(HR 2.51,95% CI 1.33 - 4.75;HR 1.86,95% CI 0.96 - 3.61)。基线LVEF+LVEDD的低水平和高水平均与PD患者全因死亡和心血管死亡风险增加相关。